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Objective To determine the quality and limitations of this technique to
study the intracardiac anatomy in complex outflow tract defects. The sec-
ondary objective is to generate the CT scan views in preoperative assessment
fitting precisely to the surgical views.
Methods and results We performed CT scans with high resolution in
15 heart specimens with double outlet right ventricle. All 3D images were pro-
duced with a 3D reconstruction platform from Paris Descartes University. The
3D view from the right ventricle showed the anatomic details for all hearts.
We described the VSD, its localization, borders and surface. We described
also the relationship with the aorta and the pulmonary trunk and the conal
septum (length and orientation). The 3D view from the right atrium was more
difficult then expected and needs to be improved. 
Conclusion This study summarizes the role of 3D scan reconstruction in
congenital heart diseases as an imaging modality to increase the precision of
preoperative assessment.
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Background Intra-aortic balloon pump (IABP) is a commonly used method
of temporary circulatory support in adults. Despite the availability of paediatric
size balloons, the use of IABP in children is currently not widespread. 
Aims To describe our practice of IABP in children and to review its indi-
cations. 
Methods Single-centre retrospective study. We reviewed the medical
records of all paediatric patients (<18 years) who were supported with IABP
from April 2010 to April 2015. We compare our practice with those reported
in Pubmed (37 articles). 
Results During this period 7 patients (6 boys) had a circulatory support with
IABP. Mean age was 12.1 years (10-14) and mean weight was 46.1kg (30-61).
All were mechanically ventilated and received inotropic support at the time of
IABP deployment. 2 IABP were started before surgery to treat acute heart
failure (1 myocarditis and 1 ischemic condition). The major indication for IABP
was postoperative hemodynamic deterioration (n=5). 4 of them were related to
suboptimal cardioplegia in a context of left ventricular hypertrophy. Mean dura-
tion of IABP support was 7.1 days (2-13). All IABP catheters were inserted
through the common femoral artery. No local complication was reported. All
IABP were inserted by an intensivist without surgical help. 
Conclusion IABP is a feasible method in children with acute left ventric-
ular failure. By improving diastolic perfusion of the coronary arteries, IABP
is effective especially in case of myocardial ischemia. This life-saving tech-
nique has to be associated to conventional medical treatment of refractory low
cardiac output. Sometimes, IABP may be an alternative for effective mechan-
ical circulatory support.
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Background The Fontan procedure (atriopulmonary Fontan) and total
cavo-pulmonary connection are designed to treat univentricular heart.
Whereas peri-operative mortality has declined, the current challenge is long-
term outcome.
Objective To evaluate the outcome and quality of life of survivors with
Fontan circulation.
Methods This retrospective monocentric study aimed patients who had
follow-up after Fontan surgery at the University Hospital of Lille. Data were
collected on medical records. The quality of life was evaluated between June
and October 2014 by two scales: Paediatric Quality of Life Inventory TM
(PedsQL) before 26 years of age and Medical Outcome Study Short Form 36
(MOS SF 36) after 26 years. 
Results Among 96 patients who underwent Fontan procedure, median
follow-up was 9.6 (6.1-12.5) years after the last intervention. Nine-year global
survival was 93%. 95% of patients had total cavo-pulmonary connection and
5% had atrio-pulmonary connection. Arrhythmia occurred in 27.1%, single
ventricle dysfunction in 87.4%, leak of the atrio-ventricular valve in 58.9%.
Protein-losing enteropathy affected 4.2% of patients and thromboembolic
events appeared in 17.7%. Total score of quality of life was 66.5% according
to the PedsQL and 62.5% to the MOS SF36. 
Conclusion This French cohort of survivors with Fontan circulation has
the same initial characteristics than which described in the literature. The level
of quality of life was comparable to general population. The question of global
rehabilitation of these patients must be raised. 
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Background Levosimendan is an inodilator agent belonging to the family
of calcium sensitizer agents. Its positive inotropic and vasodilating properties
make it interesting for the treatment of heart failure. Although this inotropic
drug is increasingly used in children, a special license is still needed to obtain
it in several countries. 
Aims To report our experience of levosimendan and to analyse its effects
in children. 
Methods It was a single-centre retrospective study. From January 2010 to
December 2014, all paediatric patients who received at least one perfusion of
levosimendan were included. Levosimendan was administered as continuous
infusions at a dose of 0.2 μg/kg/min for 24 hours without any loading dose.
Medical records were analyzed for each patient.
Results More than 200 patients received levosimendan during the
period and more than 300 infusions were performed. No side effect was
reported. Levosimendan significantly improved BNP level. Indications of
levosimendan infusion were: 1) treatment of postoperative hemodynamic
deterioration, 2) preoperative conditioning, 3) treatment of acute heart
failure (myocardial ischemia, myocarditis, decompensated cardiomyopa-
thies), 4) treatment of chronic heart failure (cardiomyopathies and failing
Fontan). 
Conclusion Because of the long half-life of its active metabolite, levosim-
endan has a prolonged effect lasting for up to 7 to 9 days after discontinuation
of a 24-hour infusion. Using this drug, the potential of arrhythmia is reduced
as total intracellular calcium levels are not raised. This inodilator agent is safe
and effective for the treatment of heart failure in children and must be part of
the conventional therapeutic arsenal.
The author hereby declares no conflict of interest
